Silver Book Fact

Fact image

The Impact of Personalized Medicine on Cancer Survival in Years

Munoz, J and R Kurzrock. Targeted Therapy in Rare Cancers: Adopting the orphans. Nat Rev Clin Oncol. 2012; 9(11): 631-42. http://www.ncbi.nlm.nih.gov/pubmed/22965154

Reference

Title
Targeted Therapy in Rare Cancers: Adopting the orphans
Publication
Nat Rev Clin Oncol
Publication Date
2012
Authors
Munoz, J and R Kurzrock
Volume & Issue
Volume 9, Issue 11
Pages
631-42
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Close to one third of all drugs currently in the biopharmaceutical pipeline are for cancer, with around 5,500 potential first-in-class cancer medicines in development.  
  • Decline in Cancer Death Rates in Men
     
  • According to the Pharmaceutical Research and Manufacturers of America, researchers are currently working on 646 medicines for cancer. All are either in clinical trials or under FDA review. …  
  • A drug for testicular cancer that cost an estimated $56 million to develop led to a sharp increase in survival rate and an annual return of $166 million in treatment…  
  • Drugs like bevacizumab- designed to impede the growth of blood vessels and tumors- can cost more than $100,000 per patient.